WO2025163413 - COMPOSITIONS FOR BLOOD ALCOHOL REDUCTION AND LIVER DETOXIFICATION IN ANIMAL OR HUMAN SUBJECTS
National phase entry is expected:
Publication Number
WO/2025/163413
Publication Date
07.08.2025
International Application No.
PCT/IB2025/050475
International Filing Date
16.01.2025
Title **
[English]
COMPOSITIONS FOR BLOOD ALCOHOL REDUCTION AND LIVER DETOXIFICATION IN ANIMAL OR HUMAN SUBJECTS
[French]
COMPOSITIONS POUR LA RÉDUCTION DU TAUX D'ALCOOL DANS LE SANG ET LA DÉTOXIFICATION DU FOIE CHEZ DES SUJETS ANIMAUX OU HUMAINS
Applicants **
LAPOINTE, Julie
LAPOINTE, Michael
Inventors
LAPOINTE, Julie
LAPOINTE, Michael
Priority Data
2401422.7
02.02.2024
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2291 | |
| EPO | Filing, Examination, Granting | 10612 | |
| Japan | Filing, Examination, Granting | 2309 | |
| South Korea | Filing, Examination, Granting | 2469 | |
| USA | Filing, Examination, Granting | 7740 |
Total:
25,421
Contact Us
Abstract[English]
Disclosed is a composition or medicament consisting, comprising or comprising essentially of, the ingredients (L, D or LD) methionine, vitamin C, a magnesium compound, vitamin B3 and vitamin B6, and it's use as a medicament for reducing blood alcohol concentration (BAC) as well as aiding detoxification of the liver. The compositions disclosed herein double and triple the rate at which BAC drops after intoxication.[French]
Titre de l'abrégé : L'invention concerne une composition ou un médicament constitué, comprenant ou comprenant essentiellement les ingrédients suivants : de la méthionine (L, D ou LD), de la vitamine C, un composé de magnésium, de la vitamine B3 et de la vitamine B6, et pouvant être utilisé en tant que médicament pour réduire la concentration d'alcool dans le sang (BAC), ainsi que pour aider à la détoxification du foie. Les compositions selon l'invention doublent et triplent la vitesse à laquelle BAC chute après intoxication alcoolique. [Figure 3 avec abrégé]